January 17, 2018
Ipsen, Exelixis promising with their treatment for patients with advanced liver cancer
Ipsen and Exelixis on Tuesday said that their phase 3 study of study of cabozantinib in patients with advanced liver…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: HCC
April 24, 2017
Tiziana testing drug for fifth most common cancer
Tiziana Life Sciences a cancer drugs making focused clinical stage biotechnology company got approval in Israel to start testing inhibitor of cell cycle dependent kinases (CDKs), milciclib in a phase II clinical trial.
February 2, 2017
NeuroVive to present hepatocellular carcinoma research results at EASL HCC Summit
NeuroVive Pharmaceutical, the mitochondrial medicine company, will present preclinical data from a new generation of sanglifehrin-based compounds with potent inhibitory…